Again, as a shareholder, potential investor, current investor, potential customer or customer, it’s always good to do some DD And hear / read the answers directly from the source
For reference, here’s a few start points of the Cc to help folks out … but, personally as an investor I’d suggest start at 4:19 mark with paper in hand and take notes - for example I was able to quickly note these minute marks just now and subsequently share to this lively discussion about Qnta : 4:19 minute mark the CC begins 6:20 minutes mark is where the Q&A from investors to qnta begins 8:56 the Armenian company question is addressed 19:00 “able to share publicly now” because they have filed for a provisional patent GREAT escozine Covid therapy data is shared
Topic: Medolife Rx (Quanta, Inc. OTC: QNTA) Investor Conference Call Date: May 12, 2022 04:52 PM Eastern Time (US and Canada)
Schoondale …. Asked “Which begs the question is family running FARMTEVSIK? Especially given the nepotism in Quanta itself. And why haven't revenues shown up in filings? “
They did show up in filings - I actually posted that information when this topic arose a few weeks ago … I’m out of the office but if you scroll back at posts you’ll see where it was noted
Schoondale also asked “Care to get an answer to that? They never seem to answer or respond to significant issues.”
I’ve got many answers by emailing them and also many questions are answered in the CC (link once again posted for reference below)
These things have been answered in other replies / posts but here it is again …
In addition to this question above so many topics were addressed and answered - I shared a link to send in questions before the cc - which many folks did just that, submitted questions/ concerns etc which were answered on the cc. I’ll share the cc link here again now for reference;
Topic: Medolife Rx (Quanta, Inc. OTC: QNTA) Investor Conference Call Date: May 12, 2022 04:52 PM Eastern Time (US and Canada)
Ultimately, the answer is No QNTA does NOT own that company in Armenia. The sale As talked about in the CC had issues because of the customs regulations surrounding the word homeopathic.. they deemed homeopathic in that country as a drug category which then held up the entire lot, as it was not being sold as a drug … Fast forward apparently the use of the word “supplement” is ok … Anyways… the Armenian company is owned by a relative but the issue at hand had zero to do with it being family but rather a government customs issue … which again Was explained on the latest cc Also I’ve posted on this thread where the initial sale was documented and filed … I suggest listening to the cc And or email MedolifeRx directly and ask
They have been transparent and most helpful in getting back to me when I’ve had questions… and the fact they have an open forum for questions to be discussed on their CC s speaks volumes… they truly do want investors to understand what’s happening in the company and things they are working toward … For example Listen at Minute mark 19:00 “able to share publicly now” because they have filed for a provisional patent GREAT escozine Covid therapy data
Key wording “able to share” … now that they have the provisional patent application That info can be shared…
There is a lot to hear on the cc. As an investor and as a customer I am personally excited for things in the works … here’s the link for those who missed
Topic: Medolife Rx (Quanta, Inc. OTC: QNTA) Investor Conference Call Date: May 12, 2022 04:52 PM Eastern Time (US and Canada)
GLTA and as always Do your Own DD Just because some posts in all caps doesn’t mean their postings have merrit Ultimately, research, listen to the CC, reach out direct to the company, try the products for yourself… in doing those things is how I became invested … I would not call this a flip… again GLTA Here’s the company investor relations page for reference and contact information https://ir.quantrx.com/
News 
Market Data 
Discover 
